Coronavirus channel feed – Endpoints News

Coronavirus channel feed

Covid-19 roundup: Cancer biotech to submit EUA for Covid drug; FDA OKs Eli Lilly JAK inhibitor

4 years ago

Emergent tossed nearly 400M Covid-19 vaccine doses in Baltimore debacle, House report says

4 years ago

ICER: Merck's Covid-19 pill doesn't show 'net health benefit' but price is reasonable

4 years ago

After racking up 41 Covid jab nods outside US, Novavax hits first profitable quarter but still disappoints investors

4 years ago

Scoop: ExeVir hits pause on llama-derived Covid antibody amid Omicron variants, shifts focus to second-gen work

4 years ago

FDA's Peter Marks to Congress: Youngest kids vaccine won't need to hit 50% efficacy mark

4 years ago

Safety risk pushes FDA to cut off J&J's Covid-19 vaccine with some limited exceptions

4 years ago

Despite Albert Bourla's comments, FDA tells doctors not to re-treat with Paxlovid if symptoms rebound

4 years ago

Potential deal reached to finalize TRIPS waiver over Covid-19 vaccine IP rights

4 years ago

FDA leaders in JAMA: This fall will kick off the 'new normal' of annual Covid-19 boosters

4 years ago

Updated: Gilead collects 5th priority review voucher as public advocacy group urged the company to relinquish it

4 years ago

For once, Pfizer's Covid pill fails in a trial — but only after seeking a much broader population

4 years ago

Moderna beats Pfizer to the punch, files EUA for Covid-19 vaccine for youngest children

4 years ago

One year later, US Trade Representative still supports an IP waiver for Covid-19 vaccines

4 years ago

Covid-19 roundup: Pfizer-BioNTech ask for kid booster EUA; Novartis, Molecular Partners may need another trial for pandemic therapy

4 years ago

Covid-19 roundup: Biden looks to increase access to Pfizer's Paxlovid; House requests update from FDA on vaccines for youngest children

4 years ago

Veklury performs better the sooner it's given, Gilead says in new study and real-world analysis

4 years ago

Covid-19 roundup: WHO issues 'strong' recommendation for Pfizer's Paxlovid but wants more price transparency

4 years ago

Serum Institute CEO, head of world's biggest vaccine maker, says Covid shot production was halted in December

4 years ago

Biotech, academic leaders encourage FDA to consider T-cell assessment in Covid-19 vaccine trials

4 years ago

AstraZeneca showcases 83% risk reduction for long-acting Covid-19 antibody at 6-month analysis

4 years ago

Still struggling to get an EUA, Novavax paints early rosy picture of combo Covid-19/flu vaccine

4 years ago

Arcturus slides on PhIII Covid-19 vaccine data, signifying the struggle in producing follow-up shots

4 years ago

Covid-19 roundup: Poland refuses to pay for more vaccine doses, triggering legal fight; Pfizer, Moderna face more investor pressure to open up mRNA tech

4 years ago

First page Previous page 9 10 111213 14 15 Next page Last page